Clarithromycin

Generic Name: clarithromycin

Macrolide Antimicrobial [EPC]Over-the-Counter (OTC)

Brand Names:

Clarithromycin

Clarithromycin is a macrolide antimicrobial agent available as 250 mg and 500 mg light yellow biconvex film-coated tablets for oral administration.

Overview

Clarithromycin is a macrolide antimicrobial agent available as 250 mg and 500 mg light yellow biconvex film-coated tablets for oral administration.

Uses

Clarithromycin tablets are indicated for treating mild to moderate infections caused by susceptible bacteria, including acute bacterial exacerbation of chronic bronchitis, acute maxillary sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin and skin structure infections, acute otitis media in pediatric patients, disseminated mycobacterial infections, and Helicobacter pylori infection with duodenal ulcer disease in adults.

Dosage

Adults: 250-500 mg every 12 hours for 7-14 days depending on infection type. H. pylori eradication: 500 mg every 8 or 12 hours for 10-14 days in combination therapy. Pediatric: 15 mg/kg/day divided every 12 hours for 10 days. Mycobacterial infections: 500 mg every 12 hours adults; 7.5 mg/kg up to 500 mg every 12 hours pediatric. Dosage adjustments required for renal impairment.

Side Effects

Most frequent: abdominal pain, diarrhea, nausea, vomiting, dysgeusia. Less frequent include taste perversion, headache, rash, dyspepsia, liver function abnormalities, anaphylactic reaction, candidiasis, insomnia. Postmarketing reports include thrombocytopenia, ventricular arrhythmia, deafness, hepatic failure, Stevens-Johnson syndrome.

Interactions

Clarithromycin inhibits CYP3A4, causing increased concentrations of substrates including disopyramide, quinidine, digoxin, warfarin, carbamazepine, itraconazole, colchicine, quetiapine, calcium channel blockers, statins, benzodiazepines, theophylline, and phosphodiesterase inhibitors. Requires monitoring or dose adjustment.

Warnings

Severe acute hypersensitivity reactions requiring immediate discontinuation. QT prolongation with risk of torsades de pointes, especially in patients with hypokalemia/hypomagnesemia or taking Class I/III antiarrhythmics. Hepatotoxicity with potential liver failure. Increased all-cause mortality 1+ years post-treatment in coronary artery disease patients. Clostridium difficile-associated diarrhea risk. Embryo-fetal toxicity in pregnant women. Hypersensitivity to clarithromycin or macrolides. Cisapride and pimozide contraindicated due to cardiac arrhythmia risk.

Pregnancy

Not recommended in pregnant women except when no alternative therapy is appropriate. Animal studies demonstrated embryo-fetal toxicity and fetal malformations.

Frequently Asked Questions

What is Clarithromycin used for?▼

Clarithromycin tablets are indicated for treating mild to moderate infections caused by susceptible bacteria, including acute bacterial exacerbation of chronic bronchitis, acute maxillary sinusitis, community-acquired pneumonia, pharyngitis/tonsillitis, uncomplicated skin and skin structure infections, acute otitis media in pediatric patients, disseminated mycobacterial infections, and Helicobacter pylori infection with duodenal ulcer disease in adults.

What are the side effects of Clarithromycin?▼

Most frequent: abdominal pain, diarrhea, nausea, vomiting, dysgeusia. Less frequent include taste perversion, headache, rash, dyspepsia, liver function abnormalities, anaphylactic reaction, candidiasis, insomnia. Postmarketing reports include thrombocytopenia, ventricular arrhythmia, deafness, hepatic failure, Stevens-Johnson syndrome.

Can I take Clarithromycin during pregnancy?▼

Not recommended in pregnant women except when no alternative therapy is appropriate. Animal studies demonstrated embryo-fetal toxicity and fetal malformations.

What are the important warnings for Clarithromycin?▼

Severe acute hypersensitivity reactions requiring immediate discontinuation. QT prolongation with risk of torsades de pointes, especially in patients with hypokalemia/hypomagnesemia or taking Class I/III antiarrhythmics. Hepatotoxicity with potential liver failure. Increased all-cause mortality 1+ years post-treatment in coronary artery disease patients. Clostridium difficile-associated diarrhea risk. Embryo-fetal toxicity in pregnant women. Hypersensitivity to clarithromycin or macrolides. Cisapride and pimozide contraindicated due to cardiac arrhythmia risk.

Related Medications

Ensulizole, Octinoxate, Octisalate, And Zinc Oxide

ensulizole, octinoxate, octisalate, and zinc oxide

Purpose Sunscreen

Apis Mellifica, Berberis Vulgaris, Cantharis, Coccus Cacti, Echinacea (angustifolia), Equisetum Hyemale, Nux Vomica, Rubia Tinctorum, Sarsaparilla, Staphysagria, Thuja Occidentalis, Zingiber Officinale

apis mellifica, berberis vulgaris, cantharis, coccus cacti, echinacea (angustifolia), equisetum hyemale, nux vomica, rubia tinctorum, sarsaparilla, staphysagria, thuja occidentalis, zingiber officinale

Standardized Insect Venom Allergenic Extract [EPC]

USES: May temporarily relieve these urinary symptoms: burning sensation frequent need to urinate painful urination** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Acetaldehyde, Coumarinum, Histaminum Hydrochloricum, Quercetin, Torula Cerevisiae, Candida Albicans, Candida Parapsilosis, Adrenocorticotrophin, Sarcolacticum Acidum, Sepia, Adrenocorticotrophin, Faecalis (alkaligenes)

acetaldehyde, coumarinum, histaminum hydrochloricum, quercetin, torula cerevisiae, candida albicans, candida parapsilosis, adrenocorticotrophin, sarcolacticum acidum, sepia, adrenocorticotrophin, faecalis (alkaligenes)

Non-Standardized Fungal Allergenic Extract [EPC]

HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to yeast syndrome including fatigue, malaise, weakness, headaches, GI disturbance, and anxiety.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Medical Disclaimer

This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.